Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake

扫码查看

原文链接

作者：

Andrew Fesler、Ga-Ram Hwang、Jingfang Ju

展开 >

作者单位：

Curamir Therapeutics Inc.,Woburn,MA 01801,USA

Department of Pathology,Renaissance School of Medicine,Stony Brook University,Stony Brook,NY 11794,USA

The Northport Veteran's Administration Medical Center,Northport,NY 11768,USA

基金：

National Institute of Health/National Cancer Institute(NIH/NCI)Curamir Therapeutics IncVA Merit Award

项目编号：

R01CA197098-01BX005260-01

出版年：

2024

DOI：

基因与疾病(英文)

ISSN：

年,卷(期)：2024.11(1)